Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016

AMES, Iowa, Oct. 24, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today reported that it will release its third quarter 2016 financial results on Tuesday, November 1,...
October 20, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016

AMES, Iowa, Oct. 20, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will webcast its Analyst and Investor Day being held on Tuesday, October...
October 04, 2016 16:10 ET | Source: NewLink Genetics Corporation

NewLink Genetics Awarded $25 Million Contract from BARDA for Investigational Ebola Zaire Vaccine (V920)

AMES, Iowa, Oct. 04, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), announced today that the Biomedical Advanced Research and Development Authority (BARDA) of the United...
September 01, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Participate in Baird Healthcare Conference

AMES, Iowa, Sept. 01, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer,...
July 29, 2016 08:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics Reports Second Quarter 2016 Financial Results

- Management to Host Conference Call Today at 8:30 a.m. ET - Analyst Day to be held on October 25 in New York AMES, Iowa , July 29, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics...
July 25, 2016 08:05 ET | Source: NewLink Genetics Corporation

NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)

AMES, Iowa, July 25, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), announced today that Merck (NYSE:MRK), known as MSD outside the United States and Canada, has reached...
July 20, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Host Its Second Quarter 2016 Financial Results Conference Call on July 29, 2016

AMES, Iowa, July 20, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today reported that it will release its second quarter 2016 financial results on Friday, July 29, 2016....
July 07, 2016 07:00 ET | Source: NewLink Genetics Corporation

NewLink Genetics to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference

AMES, Iowa, July 07, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference in New...
June 06, 2016 07:00 ET | Source: Lumos Pharma, Inc.

NewLink Genetics Presents Clinical Data for IDO Pathway Inhibitor Indoximod Combinations at American Society of Clinical Oncology (ASCO) Annual Meeting

AMES, Iowa, June 06, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients, yesterday...
June 03, 2016 07:00 ET | Source: Lumos Pharma, Inc.

NewLink Genetics to Present Data on Indoximod at American Society of Clinical Oncology (ASCO) Annual Meeting

AMES, Iowa, June 03, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will present two posters highlighting the indoleamine 2,3-dioxygenase pathway...